Association of CD206 Protein Expression with Immune Infiltration and Prognosis in Patients with Triple-Negative Breast Cancer.

Bobrie, Angélique; Massol, Océane; Ramos, Jeanne; Mollevi, Caroline; Lopez-Crapez, Evelyne; Bonnefoy, Nathalie; Boissière-Michot, Florence; Jacot, William

Bobrie, Angélique; Massol, Océane; Ramos, Jeanne; Mollevi, Caroline; Lopez-Crapez, Evelyne; Bonnefoy, Nathalie; Boissière-Michot, Florence; Jacot, William.

Afiliação

Bobrie A; Department of Medical Oncology, Institut Régional du Cancer de Montpellier (ICM), 34298 Montpellier, France.
Massol O; Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U1194, Institut du Cancer Montpellier (ICM), 34298 Montpellier, France.
Ramos J; Biometrics Unit, Institut Régional du Cancer de Montpellier (ICM), 34298 Montpellier, France.
Mollevi C; Translational Research Unit, Institut Régional du Cancer de Montpellier (ICM), 34298 Montpellier, France.
Lopez-Crapez E; Biometrics Unit, Institut Régional du Cancer de Montpellier (ICM), 34298 Montpellier, France.
Bonnefoy N; Institut Desbrest d'Epidémiologie et de Santé Publique, IDESP UMR UA11 INSERM-Université de Montpellier, 34090 Montpellier, France.
Boissière-Michot F; Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U1194, Institut du Cancer Montpellier (ICM), 34298 Montpellier, France.
Jacot W; Translational Research Unit, Institut Régional du Cancer de Montpellier (ICM), 34298 Montpellier, France.

Cancers (Basel) ; 14(19)2022 Oct 03.

Article em En | MEDLINE | ID: mdl-36230752

Palavras-chave

CD163; CD206; CD68; IRF8; prognosis; triple-negative breast cancer (TNBC); tumor-associated macrophages (TAM)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google